When it comes to innovation, the first thing you may think of is a new technology. An advancement that has never existed before, a creative design, or a way of seeing the world. But the largest and most impactful innovations here take place in the field of medicine. It can upend how countless millions of people get a fresh understanding of much less effective methods for diagnosing and treating a disease.
It will be the spirit of innovation that is celebrated at the Runway 7 Fashion Awards 2026 as neurologist and multiple sclerosis expert Dr. Fred D. Lublin. He will receive the Medical Excellence & Innovation Award. The tribute is set for September 14, 2026, at Sony Hall in New York City. It provides a night of recognition, innovation, leadership, and influence.
From your position as an observer, the award is a chance to look past the catwalk and see someone whose medical career has largely been defined by scientific advancement and a desire to improve patient care.
Recognizing a Distinguished Career in Neurology
Dr. Fred D. Lublin is an American neurologist whose career has been intimately linked with many of the major breakthroughs in the basic understanding and treatment of diseases. For example, multiple sclerosis (MS) and other central nervous system diseases.
Dr. Lublin was born in Philadelphia, Pennsylvania. He proudly earned his medical degree from Jefferson Medical College. He went on to have a distinguished career within academic medicine, clinical research, and the delivery of neurological care.
His work has gone far beyond treating individuals. He has been instrumental in establishing clinical concepts surrounding MS, the development and validation of diagnostic approaches, and the evaluation of disease-modifying therapies throughout his career.
Today, at the Icahn School of Medicine at Mount Sinai, along with the Corinne Goldsmith Dickinson Center for Multiple Sclerosis, his work may be as long as what he has given modern neurological medicine.
Dr. Lublin is the Saunders Family Professor of Neurology and Director of the Corinne Goldsmith Dickinson Center for MS. There, he has helped foster an environment in which patient care, education, and research work together.
Helping Define the Clinical Course of Multiple Sclerosis
To appreciate how much Dr. Lublin has influenced the way MS is treated, you must understand something about one of the greatest difficulties physicians have faced in treating MS. It is that “the disease does not affect every person in exactly the same way.”
Multiple sclerosis is not a single disorder but a number of diseases with distinct clinical course, symptomatology, rate of progression, and disease activity pattern. It is therefore important that we have consistent terminology for these patterns. It facilitates better communication between physicians and researchers.
Dr. Lublin became the first author to publish on standardizing clinical course definitions of multiple sclerosis and was often credited as one of the leading figures in the field.
You might be interested in reading: Izzy Lamberti to Receive Best On-Stage Performance Honor at Runway 7 Fashion Awards 2026
Advancing Modern MS Diagnosis and Research
Dr. Lublin is also involved in the changing landscape of MS diagnosis and neuroimmunology.
Integration of prospective clinical findings, neuroimaging data, laboratory results, and knowledge of the relevant measurement scales is crucial in contemporary MS care. Then, with scientific advances, physician diagnostic criteria and careful scientific history took shape, and so patients are now diagnosed more accurately at an earlier stage.
This continual evolution is informed by Dr. Lublin’s research and his role as an academic leader. His work has contributed to the global knowledge of the medical community on how MS presents and how clinicians are able to differentiate and characterize its subtypes.
In the end, for you, the implications are simple: “better classification and diagnosis can help with better research leading to better care.”
Dr. Lublin’s career has been centered on this relationship between a better understanding of the science and improved patient outcomes.
Leading Clinical Trials That Shaped Treatment
Dr. Lublin is also an important player in the entire process through his participation in the large international clinical trials to review disease-modifying therapies for multiple sclerosis.
Disease-modifying therapies have changed the treatment of MS by providing strategies that are intended to change disease activity and progression. Identifying which patient subgroups will respond—and how well—to these therapies is therefore vital and must be supported by clinical trials.
Dr. Lublin has also created a bridge between scientific discovery and its clinical application through his international research experience. His work captures an aspect of modern medicine. It is increasingly collaborative, involving researchers, physicians, institutions, and patients.
Additionally, his broad publication record indicates a strong commitment to advancing the fields of neuroimmunology and neurotherapeutics.
Leadership at Mount Sinai
Dr. Lublin is also well-known for his leadership role at Mount Sinai, where a large part of his legacy resides.
As a renowned Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis, he has helped lead a center focused on addressing MS through cutting-edge research and expert multidisciplinary care.
Such leadership is essential in the way that academic medical centers of today function. They are not places where you send patients to get cured. Also, they are the environments where physicians train, discovery science tackles unanswered questions, clinical trials occur, and innovations in care happen.
At the intersection of those activities is Dr. Lublin at Mount Sinai. In many ways, his career reflects how clinical and research can complement each other to open pathways for advances that can go well beyond the walls of even a single institution.
Why the Medical Excellence & Innovation Award Matters
Medical Excellence & Innovation Award is more than professional achievement. It mirrors a much larger ethos of innovation, leadership, action-oriented consistency, and significant influence that characterize great careers.
Dr. Lublin has always worked on those topics, and this work fits nicely into those themes.
When you think about the evolution of MS care, it is evident that such advances often happen in a series of interrelated steps:
- Better comprehension of the disease
- Consistency in clinical definitions
- Refining diagnostic strategies or potential treatments
- Translating research findings into clinical practice.
Throughout his career, Dr. Lublin has made contributions within many of these areas.
So his honor provides a chance to celebrate those kinds of innovation the public never learns about. But that can have real, lasting impacts on people’s lives.
A Career Defined by Meaningful Impact
The Medical Excellence & Innovation Award goes beyond an award announcement when you consider what Dr. Fred D. Lublin has done throughout his career. It is the recognition of decades devoted to understanding one of the world’s complex neurological diseases.
He has been involved in helping to standardize the clinical course definitions of MS, in modern thinking about diagnosis, and in participation in international clinical trials that have shaped the scientific and eventual clinical landscape of multiple sclerosis.
Under his guidance, Mount Sinai has integrated research, education, and patient care even more tightly.
On September 14, 2026, the Runway 7 Fashion Awards 2026 at Sony Hall in New York City will channel that spirit of success by presenting its Medical Excellence & Innovation Award to Dr. Fred D. Lublin.
Runway 7 Fashion Awards · Medical Excellence & Innovation Award
Dr. Fred D. Lublin
Dr. Fred D. Lublin is recognized for his groundbreaking contributions to multiple sclerosis research, neurological care and the advancement of modern diagnostic and treatment approaches. His decades of leadership connecting scientific discovery with improved patient outcomes are honored with the Medical Excellence & Innovation Award at the Runway 7 Fashion Awards 2026.
